DrugDashboards

Fexinidazole

Fexinidazole · FEXINIDAZOLE 600 mg/1 · Tablet · Oral · Sanofi-Aventis U.S. LLC

NDC 00024-4512-14 · 14 TABLET in 1 DOSE PACK · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA214429
TE code
Approval date
Jul 16, 2021
Patents / exclusivity
0 patents, 2 exclusivities
TypeNumber / codeExpires
exclusivityODE-359Jul 16, 2028
exclusivityNCEJul 16, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Fexinidazole (Tablet)

LabelerStrengthFirst seenLast seen
Sanofi-Aventis U.S. LLCFEXINIDAZOLE 600 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fexinidazole — NDC 00024-4512-14," retrieved September 3, 2026, https://drugdashboards.com/drug/00024451214.

Free to cite with attribution — see how the data is put together.